1. Alter G, Riley JC. Frailty, sickness, and death: models of morbidity and mortality in historical populations. Popul Stud (Camb). 43:25–45. 1989.
Article
2. Ayis SA, Coker B, Rudd AG, Dennis MS, Wolfe CD. Predicting independent survival after stroke: a European study for the development and validation of standardised stroke scales and prediction models of outcome. J Neurol Neurosurg Psychiatry. 84:288–296. 2013.
Article
3. Baztán JJ, Gálvez CP, Socorro A. Recovery of functional impairment after acute illness and mortality: one-year follow-up study. Gerontology. 55:269–274. 2009.
Article
4. Bortz WM 2nd. A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci. 57:M283–M288. 2002.
5. Cameron ID, Kurrle SE. Frailty and rehabilitation. Interdiscip Top Gerontol Geriatr. 41:137–150. 2015.
Article
6. Chang PE, Goh BG, Ekstrom V, Ong ML, Tan CK. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. World J Hepatol. 9:959–966. 2017.
Article
7. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 272:1036–1042. 1994.
Article
8. Dagan A, Sella T, Urban D, Onn A, Bar J, Segal G. Low alanine transaminase is not associated with increased rate of mortality in patients with advanced lung cancer. JCSM Clinical Reports. 2:1–5. 2017.
Article
9. de Souza SP, Matos RS, Barros LL, Rocha PN. Inverse association between serum creatinine and mortality in acute kidney injury. J Bras Nefrol. 36:469–475. 2014.
10. Dziedzic T. Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Rev Neurother. 15:523–531. 2015.
Article
11. Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, Stessman J. Low alanine aminotransferase activity in older people is associated with greater long-term mortality. J Am Geriatr Soc. 54:1719–1724. 2006.
Article
12. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 59:M255–M263. 2004.
Article
13. Fried LP, Tangen CM, Waltson J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 56:146–155. 2001.
14. Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol. 3:133–138. 2008.
Article
15. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC, Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 47:1363–1370. 2008.
Article
16. Le Couteur DG, Blyth FM, Creasey HM, Handelsman DJ, Naganathan V, Sambrook PN, et al. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci. 65:712–717. 2010.
Article
17. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 47:880–887. 2008.
Article
18. Lee Y, Kim J, Han ES, Ryu M, Cho Y, Chae S. Frailty and body mass index as predictors of 3-year mortality in older adults living in the community. Gerontology. 60:475–482. 2014.
Article
19. Liu Z, Ning H, Que S, Wang L, Qin X, Peng T. Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies. PLoS One. 9:e91410. 2014.
Article
20. Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke. 44:2854–2861. 2013.
Article
21. Okamura T, Hayakawa T, Hozawa A, Kadowaki T, Murakami Y, Kita Y, et al. Lower levels of serum albumin and total cholesterol associated with decline in activities of daily living and excess mortality in a 12‐year cohort study of elderly Japanese. J Am Geriatr Soc. 56:529–535. 2008.
Article
22. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 342:1266–1271. 2000.
Article
23. Schmucker DL. Age-related changes in liver structure and function: implications for disease ? Exp Gerontol. 40:650–659. 2005.
Article
24. Soud M, Alahdab F, Ho G, Kuku KO, Cejudo-Tejeda M, Hideo-Kajita A, et al. Usefulness of skeletal muscle area detected by computed tomography to predict mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis study. Int J Cardiovasc Imaging. 35:1141–1147. 2019.
Article
25. Stahon KE, Bastian C, Griffith S, Kidd GJ, Brunet S, Baltan S. Agerelated changes in axonal and mitochondrial ultrastructure and function in white matter. J Neurosci. 36:9990–10001. 2016.
Article
26. Thrift AG, Thayabaranathan T, Howard G, Howard VJ, Rothwell PM, Feigin VL, et al. Global stroke statistics. Int J Stroke. 12:13–32. 2017.
Article
27. Towfighi A, Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke. 40:2704–2708. 2009.
Article
28. Tsivgoulis G, Katsanos AH, Patousi A, Pikilidou M, Birbilis T, Mantatzis M, et al. Stroke recurrence and mortality in northeastern Greece: the Evros Stroke Registry. J Neurol. 265:2379–2387. 2018.
Article
29. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 40:e380–e389. 2009.